Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,789 | 27,750 | 29,622 | 43,576 | 35,442 |
| Marketable Securities | 2,016 | 4,961 | 8,874 | 45 | 50 |
| Receivables | 638 | 405 | 235 | 77 | 745 |
| TOTAL | $50,997 | $34,401 | $40,390 | $45,716 | $38,441 |
| Non-Current Assets | |||||
| PPE Net | 2,251 | 2,013 | 2,018 | 2,104 | 2,245 |
| Intangibles | 57,212 | 57,212 | 57,212 | 57,212 | 57,234 |
| Other Non-Current Assets | 2,758 | 2,968 | 3,182 | 3,451 | 3,099 |
| TOTAL | $62,221 | $62,193 | $62,412 | $62,767 | $62,578 |
| Total Assets | $113,218 | $96,594 | $102,802 | $108,483 | $101,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,437 | 4,477 | 5,018 | 5,683 | 6,270 |
| Other current liabilities | 7,388 | N/A | 9,142 | N/A | N/A |
| TOTAL | $13,977 | $13,864 | $15,275 | $16,890 | $17,960 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 8,250 | N/A | 10,106 | 10,808 |
| Other Non-Current Liabilities | 7,433 | 1,500 | 1,781 | 2,090 | 1,918 |
| TOTAL | $22,229 | $17,936 | $20,652 | $20,603 | $21,036 |
| Total Liabilities | $36,206 | $31,800 | $35,927 | $37,493 | $38,996 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 228,356 | 188,837 | 188,837 | 188,798 | 188,534 |
| Common Shares | 484,722 | 469,268 | 467,928 | 466,571 | 451,343 |
| Retained earnings | -403,465 | -400,192 | -397,158 | -391,398 | -384,856 |
| Other shareholders' equity | -4,245 | -4,282 | -3,895 | -4,183 | -4,464 |
| TOTAL | $77,012 | $64,794 | $66,875 | $70,990 | $62,023 |
| Total Liabilities And Equity | $113,218 | $96,594 | $102,802 | $108,483 | $101,019 |